Stock Comparison
ARGX vs KRYS
argenx NV ADR and Krystal Biotech Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$10.97B
P/E (TTM)
39.4
49.8
Forward P/E
34.0
54.6
Price/Sales
11.7
26.3
Price/Book
7.5
8.6
EV/EBITDA
33.9
54.8
Dividend Yield
—
—
Profitability
Net Margin
31.40%
53.90%
Operating Margin
30.00%
46.10%
Return on Equity
20.20%
19.90%
Return on Assets
8.86%
9.04%
Growth (YoY)
Revenue Growth
62.60%
31.90%
Earnings Growth
114.00%
52.50%
Price & Risk
Beta
-0.0
0.5
52-Week High
$934.62
$376.28
52-Week Low
$510.06
$130.50
Analyst Target
$1,041.14
$349.78
Compare ARGX and KRYS your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.